Notices from August 19, 2021 to August 20, 2021
HEALTH
Funding Opportunities
- Assessing Immune Memory (AIM)
- Blueprint MedTech Translator (UG3 UH3 – Clinical Trial Optional)
- Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)
- Blueprint MedTech: Small Business Translator (U44 – Clinical Trial Optional)
- Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01 Clinical Trial Optional) and Deciphering Immune-CNS interactions in HIV utilizing in-vitro and in-vivo model systems (R21 Clinical Trial Not Allowed)
- HIV Prevention and Alcohol (R01 and R34 Clinical Trials Optional)
- Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD ADRD (R01 Clinical Trial Not Allowed)
- Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
Meetings
- National Cancer Institute; Notice of Meeting
- Office of the Director, National Institutes of Health; Notice of Meeting
SCIENCE / TECHNOLOGY / ENGINEERING / MATH
Funding Opportunities
- Broad Agency Announcement for 3D Lidar Data
- FY2022 Vannevar Bush Faculty Fellowship (VBFF) Program
- FY21 Missile Defense Agency (MDA) Science, Technology, Engineering & Mathematics (STEM) Broad Agency Announcement (BAA)
- Research Experiences for Teachers (RET) in Engineering and Computer Science
- Science and Technology Projects Related to Coal Mining and Reclamation; Applied Science Projects